Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dacogen induction prior to HCT in MDS
NCT01333449Phase 2Terminated
- Sponsor
- Singapore General Hospital
- Start
- Jul 2010
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine in myelodysplastic syndrome (MDS), sponsored by Singapore General Hospital. Started Jul 2010; status: terminated.
02
Drugs
decitabine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT01333449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01333449.